CRO Analytics, a provider of clinical research quality performance indicators, has appointed Bruce Wakeman chief commercial officer. Mr. Wakeman will be responsible for CRO Analytics’ overall commercial strategy and execution, and will implement marketing, sales, and commercial operations and infrastructure for the launch of the company’s flagship product, Performer.  Most recently, Mr. Wakeman served as vice president, U.S. business development at Worldwide Clinical Trials. His twenty-year c...